Hematology/Oncology

Top Story

Online information on pancreatic cancer often above reading level of general population

May 4, 2016

Online health information regarding pancreatic cancer often overestimated the reading level of the general population and lacked accurate information about alternative therapeutic options, according to study results published in JAMA Surgery.

“As a pancreatic surgeon, I noticed a variable level of knowledge on the complex topic of treatment among my patients, as well as a variable level of research that patients and families have done during the treatment period,” Tara S. Kent, MD, MS, assistant professor of surgery at Harvard Medical School and program director of the general surgery residency at Beth Israel Deaconess Medical Center, told HemOnc Today. “The Internet is varied, so we wanted to see what information was most searchable, whether or not it was accurate, and whether it was written in a way that most people could understand.”

Stivarga increases OS in patients with unresectable HCC

May 4, 2016
Bayer announced results of its phase 3 RESORCE clinical trial, indicating Stivarga improved overall survival in patients with unresectable hepatocellular carcinoma.In…
In the Journals

ACP, AAIM call for changes to graduate medical education financing

May 4, 2016
The American College of Physicians and the Alliance for Academic Internal Medicine have issued a policy paper outlining recommendations for aligning graduate medical…

Oncology Nursing Society presents award to AACR CEO

May 4, 2016
Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research, received the Honorary Member Award at the opening ceremony of the Oncology Nursing…
Meeting News CoverageVideo

VIDEO: Some women with early-stage breast cancer can safely avoid adjuvant chemotherapy

May 4, 2016
NEW ORLEANS — Hatem Soliman, MD, assistant member of the women’s oncology and breast cancer department at Moffitt Cancer Center, discusses the implications…
More News Headlines »
CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Video

VIDEO: Tumor-infiltrating lymphocytes may predict response to immunotherapy in breast cancer

April 28, 2016
More »
Featured
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan